AVN 63.71 Increased By ▲ 0.02 (0.03%)
BOP 8.77 Decreased By ▼ -0.01 (-0.11%)
CHCC 134.55 Increased By ▲ 0.05 (0.04%)
DCL 10.01 Decreased By ▼ -0.04 (-0.4%)
DGKC 108.01 Increased By ▲ 0.01 (0.01%)
EFERT 64.27 Decreased By ▼ -0.18 (-0.28%)
EPCL 41.21 Decreased By ▼ -0.09 (-0.22%)
FCCL 21.00 No Change ▼ 0.00 (0%)
FFL 15.10 Increased By ▲ 0.05 (0.33%)
HASCOL 15.05 Decreased By ▼ -0.03 (-0.2%)
HBL 130.50 Decreased By ▼ -0.60 (-0.46%)
HUBC 81.75 Increased By ▲ 0.13 (0.16%)
HUMNL 7.35 Decreased By ▼ -0.05 (-0.68%)
JSCL 24.29 No Change ▼ 0.00 (0%)
KAPCO 28.49 Increased By ▲ 0.14 (0.49%)
KEL 3.70 Decreased By ▼ -0.01 (-0.27%)
LOTCHEM 11.72 Decreased By ▼ -0.03 (-0.26%)
MLCF 41.98 Increased By ▲ 0.13 (0.31%)
OGDC 93.20 Decreased By ▼ -0.13 (-0.14%)
PAEL 32.90 Decreased By ▼ -0.02 (-0.06%)
PIBTL 12.76 Decreased By ▼ -0.10 (-0.78%)
PIOC 95.00 No Change ▼ 0.00 (0%)
POWER 9.75 Decreased By ▼ -0.02 (-0.2%)
PPL 83.50 Decreased By ▼ -0.10 (-0.12%)
PSO 200.02 Increased By ▲ 0.02 (0.01%)
SNGP 56.52 Decreased By ▼ -0.08 (-0.14%)
STPL 13.15 No Change ▼ 0.00 (0%)
TRG 46.90 Increased By ▲ 0.30 (0.64%)
UNITY 23.05 Increased By ▲ 0.05 (0.22%)
WTL 1.04 Decreased By ▼ -0.01 (-0.95%)
BR100 4,133 Decreased By ▼ -155.2 (-3.62%)
BR30 21,019 Decreased By ▼ -858.48 (-3.92%)
KSE100 39,888 Decreased By ▼ -1298.86 (-3.15%)
KSE30 16,750 Decreased By ▼ -546.72 (-3.16%)
COVID-19 TOTAL DAILY

ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has fixed the maximum retail prices (MPR) of 253 drugs on the basis of its packing sizes with certain other conditions.

According to a notification issued by DRAP, the decision was made with the approval from the federal government and in exercise of powers conferred by clause (a) of section 7 of the Drug Regulatory Authority of Pakistan Act, 2012 (XXI of 2012) read with section 12 of the Drugs Act, 1976 (XXXI of 1976).

The maximum retail price will be subject to the conditions like importers and manufacturers of drug will furnish MRP of the drug to the Division of Costing and Pricing of the DRAP while the MRP will be printed on the label in the manner prescribed by the Drugs (Labelling and Packing) Rules, 1986.

Similarly, MRP as mentioned in column (4) of the notification table will not be applicable on drugs whose registrations under sub-rule (4) of rule 29 of the Drug (Licensing, Registration and Advertising) Rules, 1976 were issued before the issuance of this notification, unless otherwise stated expressively, the notification said.

As per notification, a four-column table has been formed to fix maximum retail prices specified in column 4 of the table on which the drugs specified in column 2 having packing sizes specified in column 3, will be sold, subject to the conditions specified in paragraph 2 of the notification.

These medicines were related to high blood pressure, cancer, hepatitis and other diseases.

It is pertinent to mention here that the Ministry of National Health Services had referred the matter of fixing drug prices as per packing size to the federal cabinet one month back, which was approved by the cabinet after detailed discussion.